Executive Moves
EnteroMedics Names Entrepreneur Gladney as New CEO
|
EnteroMedics Inc. (ETRM), the developer of a device to treat obesity and metabolic diseases, named Dan Gladney as its new chief executive, as founder Mark Knudson retires.
Executive Moves
Glaxo’s Former Head of Biopharmaceutical Research Joins F-Star
|
F-Star, a clinical-stage developer of antibodies to treat cancer, named former GlaxoSmithKline (GSK) executive Neil Brewis as its chief scientific officer.
Markets
Growth Equity Financing Market Grew 11% in Q3 Before Market Slowdown
|
The equity financing market for emerging growth companies grew 11% in deal volume and 18% in total dollars last quarter, driven by investors’ enthusiasm for biotech companies.
But biotech deal flow has slowed in recent weeks as the market correction led investors to avoid risky stocks, raising concerns going forward.
News
SEC Approves JOBS Act Crowdfunding Rules
|
It’s official: small companies will soon be able to sell equity to anyone, as long as the sales are executed through a regulated Internet portal or broker-dealer.
It took the Securities and Exchange Commission three-and-a-half years to finalize and pass rules to enact Title III of the Jumpstart Our Business Startups Act, which will allow businesses to sell stock through online crowdfunding campaigns. Those rules still will not take effect until 180 days after
